Pfizer (PFE)

$28.05 0.35 (1.26%)

19:00 EDT PFE Stock Quote Delayed 30 Minutes

Top 3 Healthcare Stock Picks for the New Year

By Charles Munyi, InvestorPlace Contributor Dec 25, 2023

Buy these healthcare stocks for 2024 trading at bargain prices before their earnings inflect higher on improving fundamentals.

3 Blue-Chip Stocks Set for a 50% Surge in the Coming Year

3 Stocks to Snatch Up on Tax-Loss Harvesting Dips

3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?

Volume:

Previous Close -

Market Cap 157.27B

PE Ratio -561.00

EPS -0.05

Volume (Avg. Vol.) 17.26M

Day's Range $27.67 - $28.09

52-Week Range $25.20 - $37.80

Dividend & Yield $1.64 (5.85%)

PFE Stock Predictions, Articles, and Pfizer News

3 of the Most Attractive Dividend Stocks in the Pharma Space

By Muslim Farooque, InvestorPlace Contributor Dec 17, 2023

Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

By Josh Enomoto, InvestorPlace Contributor Dec 17, 2023

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…

3 Stocks That Are About to Get Absolutely Crushed

By Noah Bolton, InvestorPlace Contributor Dec 14, 2023

These are a few different companies that are experiencing difficult times and that are expected to keep falling.

3 Sleepy Stocks Ready to Wake up in 2024

By Chris Markoch, InvestorPlace Contributor Dec 13, 2023

Strong projected earnings growth makes these three stocks strong candidates for exceptional growth in 2024.

Seeking Passive Income? 7 Dividend Stocks You Don’t Want to Miss.

By Yiannis Zourmpanos, InvestorPlace Contributor Dec 13, 2023

The quest for stable investment avenues beckons toward dividend stocks, offering a beacon of financial security and passive income.

3 Blue-Chip Stocks Set to Make a Comeback in 2024

By Faisal Humayun, InvestorPlace Contributor Dec 8, 2023

These are the blue-chip stocks to buy as they represent quality companies with a steady growth outlook and promising cash flow growth.

7 Tech Stocks to Light Up Your Portfolio This Holiday Season

By Yiannis Zourmpanos, InvestorPlace Contributor Dec 8, 2023

As the holiday season approaches, the tech stock market shines brightly, with innovative sparks illuminating various sectors.

7 F-Rated Stocks to Sell in December

By Louis Navellier and the InvestorPlace Research Staff Dec 8, 2023

Life is short. Time relentlessly moves forward, transforming seconds and minutes into hours and days. Before you know it, it’s nearly the end of 2023…

Diamonds in the Rough: 3 Undervalued Stocks with Huge Upside

By Chandler Capital, InvestorPlace Contributor Dec 5, 2023

These three, undervalued stocks that have reliable and massive earnings growth potential may yield a pleasant surprise.

7 Compelling Stocks to Buy That are Sitting at 52-Week Lows

By Josh Enomoto, InvestorPlace Contributor Dec 5, 2023

In arguably most circumstances, when you see stocks at 52-week lows, you should avoid them. Based on prevailing market theory, equity valuations culminate from the…

Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts

By William White, InvestorPlace Writer Dec 1, 2023

Pfizer layoffs are on the way for workers at the company's Groton, Conn. facility as it seeks to reduce costs by cutting jobs.

Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love

By Rich Duprey, InvestorPlace Contributor Nov 30, 2023

Buying stocks simple for their high dividend yields is risky but these are three stocks the elite love regardless.

3 Top-Rated Value Stocks That Analysts Are Loving Now

By Ian Bezek, InvestorPlace Contributor Nov 27, 2023

Stuff your stockings with these top-rated value stocks. Analysts are feeling good about this value stocks heading into 2024.

Dual Powerhouses: 7 Dividend Stocks Marrying High Yield With High Growth

By Josh Enomoto, InvestorPlace Contributor Nov 20, 2023

While it’s always important to consider passive-income providers, they often lack an underlying growth impetus, which subsequently makes the concept of high-yield dividend growth stocks…

The 7 Most Undervalued Sleeper Stocks to Buy Now: November 2023

By Alex Sirois, InvestorPlace Contributor Nov 19, 2023

Undervalued sleeper stocks always offer potential bargains to investors at cheap prices that can multiply investments quickly

3 Long-Term Stocks You’ll Regret Not Buying Soon: November 2023

By Muslim Farooque, InvestorPlace Contributor Nov 16, 2023

Discover three of the best long-term stocks to buy soon that are poised for success amidst the currently uncertain economic scenario.

3 Undervalued Growth Stocks to Double Your Wealth in 2024

By Josh Enomoto, InvestorPlace Contributor Nov 14, 2023

While a certain confidence in betting with the masses exist, investors wanting to up the ante may consider undervalued growth stocks. To better frame the…

Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts

By Joel Baglole, InvestorPlace Contributor Nov 14, 2023

Investors should be aware of the Pfizer layoffs and cost-cutting measures as its Covid-19 sales and stock price continue to slump.

7 Undervalued Stocks With Potential to Hit Trillion-Dollar Milestone

By Josh Enomoto, InvestorPlace Contributor Nov 11, 2023

When discussing the next trillion-dollar companies, this article will either be prescient or a total clown show. And while there’s good evidence to suggest that…

7 Blue-Chip Stocks to Sell and Never Buy Back

By Joel Baglole, InvestorPlace Contributor Nov 10, 2023

Investors would be smart to part ways with these troubled blue-chip stocks to sell, each of which has seen its share price erode.

Pfizer (PFE)

Top 3 Healthcare Stock Picks for the New Year

3 Blue-Chip Stocks Set for a 50% Surge in the Coming Year

3 Stocks to Snatch Up on Tax-Loss Harvesting Dips

3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pfizer (PFE)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PFE Stock Predictions, Articles, and Pfizer News

Subscriber Sign in